Katabi Maha 4
4 · Aerovate Therapeutics, Inc. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
Katabi Maha
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2024-01-02$13.49/sh+3,519$47,471→ 3,519 totalExercise: $21.81Exp: 2034-01-01→ Common Stock (3,519 underlying)
Footnotes (1)
- [F1]This option was awarded in lieu of cash compensation pursuant to the Issuer's Non-Employee Director Compensation Policy. The shares underlying such option shall vest and become exercisable in four equal installments, with the first installment vesting on March 31, 2024, the second installment vesting on June 30, 2024, the third installment vesting on September 30, 2024, and the fourth installment vesting on December 31, 2024.